Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 38.47 is 150% above its 5-year average of 15.41, near the high end of its 5-year range (-27.02–38.55).
As of the fiscal period ended Tuesday, March 31, 2026. 19.45% above its 12-month average of 32.20.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
38.47
EARNINGS PER SHARE (EPS) AVG TTM
32.20
EARNINGS PER SHARE (EPS) AVG 3Y
28.04
EARNINGS PER SHARE (EPS) AVG 5Y
15.41
EARNINGS PER SHARE (EPS) AVG 10Y
11.88
EARNINGS PER SHARE (EPS) AVG 15Y
12.38
EARNINGS PER SHARE (EPS) AVG 20Y
4.48
CURRENT VS TTM AVG
+19.45%
CURRENT VS 3Y AVG
+37.17%
CURRENT VS 5Y AVG
+149.62%
CURRENT VS 10Y AVG
+223.77%
CURRENT VS 15Y AVG
+210.81%
CURRENT VS 20Y AVG
+759.47%
McKesson Corporation
Market Cap
$99.85B
Earnings Per Share (EPS)
38.47
TTM Avg
32.20
3Y Avg
28.04
5Y Avg
15.41
Market Cap
$88.12B
Earnings Per Share (EPS)
29.87
TTM Avg
25.45
3Y Avg
22.39
5Y Avg
20.36
Market Cap
$82.25B
Earnings Per Share (EPS)
22.50
TTM Avg
25.49
3Y Avg
25.23
5Y Avg
24.07
Market Cap
$119.50B
Earnings Per Share (EPS)
16.86
TTM Avg
6.69
3Y Avg
10.10
5Y Avg
9.99
Market Cap
$78.54B
Earnings Per Share (EPS)
40.43
TTM Avg
41.98
3Y Avg
40.38
5Y Avg
45.10
Market Cap
$74.70B
Earnings Per Share (EPS)
24.16
TTM Avg
17.27
3Y Avg
18.45
5Y Avg
18.81
Market Cap
$128.20B
Earnings Per Share (EPS)
9.65
TTM Avg
8.18
3Y Avg
7.73
5Y Avg
6.75
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| McKesson Corporation (MCK) | $99.85B | 38.47 | 32.20 | 28.04 | 15.41 |
| GSK plc (GSK)vs › | $102.56B | 4.52 | 4.58 | 5.32 | 4.82 |
| Medtronic plc (MDT)vs › | $110.42B | 3.73 | 3.69 | 3.25 | 3.23 |
| HCA Healthcare, Inc. (HCA)vs › | $88.12B | 29.87 | 25.45 | 22.39 | 20.36 |
| Elevance Health Inc. (ELV)vs › | $82.25B | 22.50 | 25.49 | 25.23 | 24.07 |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $119.50B | 16.86 | 6.69 | 10.10 | 9.99 |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $78.54B | 40.43 | 41.98 | 40.38 | 45.10 |
| Cigna Corporation (CI)vs › | $74.70B | 24.16 | 17.27 | 18.45 | 18.81 |
| Stryker Corporation (SYK)vs › | $128.20B | 9.65 | 8.18 | 7.73 | 6.75 |
| Boston Scientific Corporation (BSX)vs › | $70.80B | 2.46 | 1.61 | 1.19 | 0.89 |
Trailing EPS (TTM)
$38.47
Forward EPS (Est.)
$39.01
P/E Ratio
22.3
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-03-31 | 38.55 |
| 2025-03-31 | 25.86 |
| 2024-03-31 | 22.54 |
| 2023-03-31 | 25.23 |
| 2022-03-31 | 7.31 |
| 2021-03-31 | -27.02 |
| 2020-03-31 | 4.97 |
| 2019-03-31 | 0.17 |
| 2018-03-31 | 0.32 |
| 2017-03-31 | 22.95 |
| 2016-03-31 | 9.82 |
| 2015-03-31 | 6.37 |
| 2014-03-31 | 5.51 |
| 2013-03-31 | 5.71 |
| 2012-03-31 | 5.70 |
| 2011-03-31 | 4.65 |
| 2010-03-31 | 4.70 |
| 2009-03-31 | 2.99 |
| 2008-03-31 | 3.40 |
| 2007-03-31 | 3.06 |
| 2006-03-31 | 2.46 |
| 2005-03-31 | -0.53 |
| 2004-03-31 | 2.23 |
| 2003-03-31 | 1.92 |
| 2002-03-31 | 1.47 |
| 2001-03-31 | -0.17 |
| 2000-03-31 | 2.57 |
| 1999-03-31 | 0.31 |
| 1998-03-31 | 1.66 |
| 1997-03-31 | 0.83 |
Reported annual fiscal-period values; no daily interpolation.
